Evidence map›Paper›PMID 28986540›Full record

ArticleScientific reports2017

Reactive metabolites of acetaminophen activate and sensitize the capsaicin receptor TRPV1.

Mirjam J Eberhardt, Florian Schillers, Esther M Eberhardt, Linus Risser, Jeanne de la Roche, Christine Herzog, Frank Echtermeyer, Andreas Leffler

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Oxidation of methionine residues activates the high-threshold heat-sensitive ion channel TRPV2.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  15. Review
  16. Is TRPA1International journal of molecular sciences · 2019
    Review
  17. Article
  18. Review
  19. Article
  20. Nanoparticles-Mediated Modulation of TRP Channels: Advances and Therapeutic Potential.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Mirjam J EberhardtDepartment of Anaesthesiology and Intensive Care Medicine, Hannover Medical School, Hannover, Carl-Neuberg-Strasse 1, 30625, Hannover, Germany.
Florian SchillersDepartment of Anaesthesiology and Intensive Care Medicine, Hannover Medical School, Hannover, Carl-Neuberg-Strasse 1, 30625, Hannover, Germany.
Esther M EberhardtDepartment of Anaesthesiology, Friedrich-Alexander-University Erlangen-Nuremberg, Krankenhausstrasse 12, 91054, Erlangen, Germany.
Linus RisserDepartment of Anaesthesiology and Intensive Care Medicine, Hannover Medical School, Hannover, Carl-Neuberg-Strasse 1, 30625, Hannover, Germany.
Jeanne de la RocheInstitute for Neurophysiology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625, Hannover, Germany.ORCID 0000-0001-5753-1732
Christine HerzogDepartment of Anaesthesiology and Intensive Care Medicine, Hannover Medical School, Hannover, Carl-Neuberg-Strasse 1, 30625, Hannover, Germany.
Frank EchtermeyerDepartment of Anaesthesiology and Intensive Care Medicine, Hannover Medical School, Hannover, Carl-Neuberg-Strasse 1, 30625, Hannover, Germany.
Andreas LefflerDepartment of Anaesthesiology and Intensive Care Medicine, Hannover Medical School, Hannover, Carl-Neuberg-Strasse 1, 30625, Hannover, Germany. leffler.andreas@mh-hannover.de.
Medizinische Hochschule Hannover · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The irritant receptor TRPA1 was suggested to mediate analgesic, antipyretic but also pro-inflammatory effects of the non-opioid analgesic acetaminophen, presumably due to channel activation by the reactive metabolites parabenzoquinone (pBQ) and N-acetyl-parabenzoquinonimine (NAPQI). Here we explored the effects of these metabolites on the capsaicin receptor TRPV1, another redox-sensitive ion channel expressed in sensory neurons. Both pBQ and NAPQI, but not acetaminophen irreversibly activated and sensitized recombinant human and rodent TRPV1 channels expressed in HEK 293 cells. The reducing agents dithiothreitol and N-acetylcysteine abolished these effects when co-applied with the metabolites, and both pBQ and NAPQI failed to gate TRPV1 following substitution of the intracellular cysteines 158, 391 and 767. NAPQI evoked a TRPV1-dependent increase in intracellular calcium and a potentiation of heat-evoked currents in mouse spinal sensory neurons. Although TRPV1 is expressed in mouse hepatocytes, inhibition of TRPV1 did not alleviate acetaminophen-induced hepatotoxicity. Finally, intracutaneously applied NAPQI evoked burning pain and neurogenic inflammation in human volunteers. Our data demonstrate that pBQ and NAQPI activate and sensitize TRPV1 by interacting with intracellular cysteines. While TRPV1 does not seem to mediate acetaminophen-induced hepatotoxicity, our data identify TRPV1 as a target of acetaminophen with a potential relevance for acetaminophen-induced analgesia, antipyresia and inflammation.

Indexed as

MetabolomeAcetaminophenAnimalsBenzoquinonesCalciumCapsaicinCell DeathCysteineGanglia, SpinalHEK293 CellsHepatocytesHumansIminesIntracellular SpaceIon Channel GatingMaleAcetaminophenBenzoquinonesCalciumCapsaicinCysteineIminesN-acetyl-4-benzoquinoneiminequinoneReducing AgentsTRPV1 receptorTRPV Cation Channels

Identifiers

PMID28986540
PMCPMC5630573
OpenAlexW2763827951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.